Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VISTA PHARMA vs PARMAX PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VISTA PHARMA PARMAX PHARMA VISTA PHARMA/
PARMAX PHARMA
 
P/E (TTM) x -5.9 -2.5 - View Chart
P/BV x 1.6 1.8 90.7% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 VISTA PHARMA   PARMAX PHARMA
EQUITY SHARE DATA
    VISTA PHARMA
Mar-23
PARMAX PHARMA
Mar-23
VISTA PHARMA/
PARMAX PHARMA
5-Yr Chart
Click to enlarge
High Rs1458 25.0%   
Low Rs726 24.7%   
Sales per share (Unadj.) Rs0.330.2 0.9%  
Earnings per share (Unadj.) Rs-1.5-0.2 739.2%  
Cash flow per share (Unadj.) Rs-1.33.5 -38.6%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs8.111.5 70.8%  
Shares outstanding (eoy) m37.565.10 736.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x39.11.4 2,811.2%   
Avg P/E ratio x-6.9-205.9 3.4%  
P/CF ratio (eoy) x-7.812.1 -64.5%  
Price / Book Value ratio x1.33.7 35.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m393214 183.5%   
No. of employees `000NANA-   
Total wages/salary Rs m528 18.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10154 6.5%  
Other income Rs m40 997.5%   
Total revenues Rs m14154 9.1%   
Gross profit Rs m-4423 -197.1%  
Depreciation Rs m619 32.9%   
Interest Rs m124 328.1%   
Profit before tax Rs m-590 -12,773.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-22 -142.7%   
Profit after tax Rs m-57-1 5,444.2%  
Gross profit margin %-442.714.7 -3,019.7%  
Effective tax rate %3.6326.5 1.1%   
Net profit margin %-563.9-0.7 83,337.2%  
BALANCE SHEET DATA
Current assets Rs m23875 315.5%   
Current liabilities Rs m14171 197.3%   
Net working cap to sales %963.02.6 37,758.5%  
Current ratio x1.71.1 159.9%  
Inventory Days Days2074 4,651.4%  
Debtors Days Days40,902147,800 27.7%  
Net fixed assets Rs m29697 305.9%   
Share capital Rs m7545 168.7%   
"Free" reserves Rs m23014 1,639.8%   
Net worth Rs m30659 521.7%   
Long term debt Rs m5245 115.6%   
Total assets Rs m534176 303.1%  
Interest coverage x-3.81.1 -341.6%   
Debt to equity ratio x0.20.8 22.2%  
Sales to assets ratio x00.9 2.2%   
Return on assets %-8.31.5 -552.8%  
Return on equity %-18.5-1.8 1,042.9%  
Return on capital %-13.14.0 -324.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m-173 -513.8%  
From Investments Rs m-13-9 135.7%  
From Financial Activity Rs m31NA -7,077.3%  
Net Cashflow Rs m1-6 -20.4%  

Share Holding

Indian Promoters % 15.6 30.8 50.7%  
Foreign collaborators % 12.2 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 72.2 69.2 104.3%  
Shareholders   13,908 2,002 694.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VISTA PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on VISTA PHARMA vs PARMAX PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

VISTA PHARMA vs PARMAX PHARMA Share Price Performance

Period VISTA PHARMA PARMAX PHARMA S&P BSE HEALTHCARE
1-Day -4.92% -2.13% 1.23%
1-Month -23.87% -8.40% -0.70%
1-Year 25.51% 1.67% 61.90%
3-Year CAGR 3.75% -7.60% 18.18%
5-Year CAGR -11.99% 10.12% 19.80%

* Compound Annual Growth Rate

Here are more details on the VISTA PHARMA share price and the PARMAX PHARMA share price.

Moving on to shareholding structures...

The promoters of VISTA PHARMA hold a 27.8% stake in the company. In case of PARMAX PHARMA the stake stands at 30.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of VISTA PHARMA and the shareholding pattern of PARMAX PHARMA.

Finally, a word on dividends...

In the most recent financial year, VISTA PHARMA paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

PARMAX PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of VISTA PHARMA, and the dividend history of PARMAX PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.